SCHEMBL29623674

SCHEMBL29623674

CCCCOC(=O)N(C)CCN(c1ccc(N)cc1)S(C)(=O)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
TSHR P16473 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
PDE4D Q08499 1/20 0.46
CYP2D6 P10635 2/20 0.43
CHRM2 P08172 1/20 0.43
HTR1A P08908 1/20 0.43
GAA P10253 1/20 0.43
DRD3 P35462 1/20 0.43
SCN1A P35498 1/20 0.43
SLC6A3 Q01959 1/20 0.43
KCNH2 Q12809 1/20 0.43
SCN2A Q99250 1/20 0.43
SCN3A Q9NY46 1/20 0.43
ALDH1A1 P00352 5/20 0.41
NPC1 O15118 3/20 0.41
MAPT P10636 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29623703 0.84 MAPT (0.47) LMNAGAAALDH1A1MAPTSMN1; SMN2
SCHEMBL21932070 0.79 SMN1; SMN2 (0.41) CYP3A4ALDH1A1SMN1; SMN2MAPK1MMP2
SCHEMBL21999069 0.79 MMP2 (0.37) GAANPC1SMN1; SMN2MMP2MMP9
SCHEMBL5626036 0.78 MMP2 (0.39) TSHRCYP3A4ALDH1A1SMN1; SMN2MAPK1
SCHEMBL28033051 0.76 LMNA (0.58) LMNATSHRCYP1A2CYP3A4CYP2C9
SCHEMBL2994448 0.74 ALDH1A1 (0.44) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5624601 0.74 MMP2 (0.36) LMNACYP3A4ALDH1A1SMN1; SMN2MAPK1
SCHEMBL3150048 0.73 CYP3A4 (0.42) LMNATSHRCYP3A4CYP2C9GAA
SCHEMBL6327814 0.73 MMP2 (0.43) LMNATSHRCYP1A2CYP3A4GAA
SCHEMBL6082056 0.72 TSHR (0.56) LMNATSHRCYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3986468-A1 ANTIB0DY-ALK5 INHIBITOR CONJUGATES AND THEIR USES Synthis Therapeutics, Inc. (US) 2022-04-27 EP disclosed